RAB32 and non-small cell lung carcinoma: Two transcripts encoding for the small GTPase RAB32 and the glycoprotein thrombospondin-1 (THBS1) were further confirmed to be detected and upregulated in liquid biopsies sampled at disease progression from EGFR-mutation-positive NSCLC patients treated with osimertinib compared with liquid biopsies sampled at treatment baseline.